Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Weight Loss 2Polycystic Ovary Syndrome 2Tumor Surgery 1Sarcopenia 1Postoperative Complications 1Obesity 1Muscle Weakness 1Metabolic Syndrome 1Intermittent Fasting 1Insulin Resistance 1Esophageal Neoplasms 1Colorectal Neoplasms 1

Interventions

Metformin 21Inositol 13Letrozole 9Exercise 5Surveys and Questionnaires 4Clomiphene 4Tablets 3Estradiol 3semaglutide 2maltodextrin 2drospirenone and ethinyl estradiol combination 2Spironolactone 2Progesterone 2Ethinyl Estradiol 2Diet Therapy 2Contraceptives, Oral, Combined 2Caloric Restriction 2Acupuncture Therapy 2salicylsalicylic acid 1mirabegron 1etonogestrel 1drospirenone 1dapagliflozin 1cetrorelix 1Walking 1Tirzepatide 1Thyroxine 1Thioctic Acid 1Tamoxifen 1Sodium-Glucose Transporter 2 Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Polycystic Ovary Syndrome × Caloric Restriction × 1 year × Clear all
NCT07380841 2026-02-02

PCOS-COMBO (9)

Islamabad Medical and Dental College

Phase NA Completed
192 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Weight Loss, Metabolic Syndrome

NCT07158723 2025-09-08

Protein and Polycystic Ovary Syndrome (PCOS)

University of Arkansas, Fayetteville

Phase NA Recruiting
60 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡